A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer

• Published in: European urology Vol. 80; no. 5; pp. 531 - 545
• Main Authors: Van den Broeck, Thomas, Oprea-Lager, Daniela, Moris, Lisa, Kailavasan, Mithun, Briers, Erik, Cornford, Philip, De Santis, Maria, Gandaglia, Giorgio, Gillessen Sommer, Silke, Grummet, Jeremy P., Grivas, Nikos, Lam, Thomas B.L., Lardas, Michael, Liew, Matthew, Mason, Malcolm, O’Hanlon, Shane, Pecanka, Jakub, Ploussard, Guillaume, Rouviere, Olivier, Schoots, Ivo G., Tilki, Derya, van den Bergh, Roderick C.N., van der Poel, Henk, Wiegel, Thomas, Willemse, Peter-Paul, Yuan, Cathy Y., Mottet, Nicolas
• Format: Journal Article
• Language: English
• Published: Switzerland Elsevier B.V 01.11.2021
• Subjects: Delivery of Health Care - standards; Evidence synthesis; Functional outcomes; Hospital volume; Hospitals; Hospitals, High-Volume; Humans; Male; Neoplasm Recurrence, Local; Oncological outcomes; Outcome Assessment, Health Care; Prostate - surgery; Prostatectomy - adverse effects; Prostatic Neoplasms - surgery; Surgeon volume; Surgeons - supply & distribution; Systematic review; Treatment Outcome; Workload; Hospital volume; Systematic review; Oncological outcomes; Functional outcomes; Evidence synthesis; Surgeon volume
• ISSN: 0302-2838; 1873-7560
• DOI: 10.1016/j.eururo.2021.04.028

The impact of surgeon and hospital volume on outcomes after radical prostatectomy (RP) for localised prostate cancer (PCa) remains unknown. To perform a systematic review on the association between surgeon or hospital volume and oncological and nononcological outcomes following RP for PCa. Medline, Medline In-Process, Embase, and the Cochrane Central Register of Controlled Trials were searched. All comparative studies for nonmetastatic PCa patients treated with RP published between January 1990 and May 2020 were included. For inclusion, studies had to compare hospital or surgeon volume, defined as caseload per unit time. Main outcomes included oncological (including prostate-specific antigen persistence, positive surgical margin [PSM], biochemical recurrence, local and distant recurrence, and cancer-specific and overall survival) and nononcological (perioperative complications including need for blood transfusion, conversion to open procedure and within 90-d death, and continence and erectile function) outcomes. Risk of bias (RoB) and confounding assessments were undertaken. Both a narrative and a quantitative synthesis were planned if the data allowed. Sixty retrospective comparative studies were included. Generally, increasing surgeon and hospital volumes were associated with lower rates of mortality, PSM, adjuvant or salvage therapies, and perioperative complications. Combining group size cut-offs as used in the included studies, the median threshold for hospital volume at which outcomes start to diverge is 86 (interquartile range [IQR] 35–100) cases per year. In addition, above this threshold, the higher the caseload, the better the outcomes, especially for PSM. RoB and confounding were high for most domains. Higher surgeon and hospital volumes for RP are associated with lower rates of PSMs, adjuvant or salvage therapies, and perioperative complications. This association becomes apparent from a caseload of >86 (IQR 35–100) per year and may further improve hereafter. Both high- and low-volume centres should measure their outcomes, make them publicly available, and improve their quality of care if needed. We reviewed the literature to determine whether the number of prostate cancer operations (radical prostatectomy) performed in a hospital affects the outcomes of surgery. We found that, overall, hospitals with a higher number of operations per year have better outcomes in terms of cancer recurrence and complications during or after hospitalisation. However, it must be noted that surgeons working in hospitals with lower annual operations can still achieve similar or even better outcomes. Therefore, making hospital’s outcome data publicly available should be promoted internationally, so that patients can make an informed decision where they want to be treated. Higher surgeon and hospital volumes for radical prostatectomy are associated with lower rates of positive surgical margins, adjuvant or salvage therapies, and perioperative complications. Centres performing radical prostatectomy surgeries should make their outcomes publicly available for benchmarking purposes.